Investigation of Locus Coeruleus Function in Sustained Attention
University of California, Davis · NCT06041048
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–60 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 4
- Target enrollment
- 40
- US sites recruiting
- 1
- Study start
- October 1, 2023
- Record last updated
- June 18, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The norepinephrine-producing locus coeruleus (LC) is thought to be central to a wide array of cognitive functions, like attention and goal pursuit, and has been implicated in dysfunctions including attention deficit hyperactivity disorder and schizophrenia. The goal of this proposal is to develop methods that permit measurement of activity in the human LC. Because the LC is small and located in the pons, the Investigators will use high resolution magnetic resonance imaging techniques tailored to the brainstem environment, including neuromelanin-sensitive images shown to delineate the LC, combined with pharmacological manipulation to confirm the location of functional activity.
Being studied: Modafinil
Conditions: Attention - no Condition is Being Assessed - Healthy Adults
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Between the ages of 18 - 60 years of age,
- Typically developing, healthy adult
Exclusion Criteria
- History of schizophrenia, other forms of psychosis,
- Specific or focal neurological disorder or severe alcohol or drug use disorder within the past 5 years
- History of left ventricular hypertrophy or in patients with mitral valve prolapse who have experienced the mitral valve prolapse syndrome when previously receiving CNS stimulants, or who have had recent history of myocardial infarction or unstable angina.
- Volunteers with known hypersensitivity to modafinil or armodafinil or its inactive ingredients
- Known allergy/sensitivity or any hypersensitivity to components of modafinil or its formulation
- Inability to swallow tablets or tolerate oral medication;
- Pregnant or nursing (participants will be required to have a negative pregnancy test)
- Contraindication for MRI scanning (metal implants, pacemakers, metal foreign bodies, or pregnancy)
- Use of psychotropic medication within the past week
- Claustrophobic and not comfortable being in a small space may also not want to participate
Recruiting US locations
University of California, Davis
Sacramento, CA 95817
Site contact: Jared Borden · jborden@ucdavis.edu
Study contacts (from the official record)
- Julie Schweitzer, PhD · 9167030450 · jschweitzer@ucdavis.edu
- Jared Borden, MA · 9167030294 · Jborden@ucdavis.edu
Similar studies in California
All healthy volunteers studies in California →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Glendale, CA + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- Rialto, CA + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Lake Forest, CA + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Phase 1 Study of SBS-147 in Healthy Adults
Sparian Biosciences, Inc
- Location
- Cypress, CA
- Eligibility basics
- Ages 18–55